CCNT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.345800E-01
Normal-vs-Stage2
3.185800E-01
Normal-vs-Stage3
7.341700E-02
Normal-vs-Stage4
3.525400E-01
Stage1-vs-Stage2
4.997600E-01
Stage1-vs-Stage3
8.191500E-02
Stage1-vs-Stage4
7.488400E-01
Stage2-vs-Stage3
1.011560E-01
Stage2-vs-Stage4
8.320600E-01
Stage3-vs-Stage4
6.225900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.122200E-01
Normal-vs-AfricanAmerican
2.006600E-01
Normal-vs-Asian
4.636400E-02
Caucasian-vs-AfricanAmerican
8.178800E-01
Caucasian-vs-Asian
2.854800E-01
AfricanAmerican-vs-Asian
4.633800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.615570E-02
Normal-vs-Female
3.059600E-01
Male-vs-Female
8.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.190400E-01
Normal-vs-Age(41-60Yrs)
3.734000E-01
Normal-vs-Age(61-80Yrs)
9.002700E-03
Normal-vs-Age(81-100Yrs)
3.106500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.981600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.465400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.342800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.888200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.828000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.765000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.803000E-01
Normal-vs-Daily Drinker
1.836180E-02
Normal-vs-Weekly Drinker
4.420300E-02
Normal-vs-Occasional Drinker
6.831500E-02
Normal-vs-Social Drinker
3.443400E-01
Non Drinker-vs-Daily Drinker
5.552600E-01
Non Drinker-vs-Weekly Drinker
8.389600E-01
Non Drinker-vs-Occasional Drinker
1.703230E-01
Non Drinker-vs-Social Drinker
3.233600E-01
Daily Drinker-vs-Weekly Drinker
7.872600E-01
Daily Drinker-vs-Occasional Drinker
9.495900E-02
Daily Drinker-vs-Social Drinker
1.769410E-01
Weekly Drinker-vs-Occasional Drinker
2.179800E-01
Weekly Drinker-vs-Social Drinker
3.325200E-01
Occasional Drinker-vs-Social Drinker
6.994800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.638000E-02
Normal-vs-Grade 2
1.695270E-03
Normal-vs-Grade 3
2.623200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.596570E-01
Grade 1-vs-Grade 3
1.567560E-01
Grade 1-vs-Grade 4
2.638000E-02
Grade 2-vs-Grade 3
7.607600E-01
Grade 2-vs-Grade 4
1.695270E-03
Grade 3-vs-Grade 4
2.623200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.546400E-01
Normal-vs-NonDiabetic
3.081600E-01
Diabetic-vs-NonDiabetic
1.327830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.507800E-01
Normal-vs-NoPancreatitis
2.935000E-01
Pancreatitis-vs-NoPancreatitis
3.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.928080E-02
Normal-vs-N1
3.242000E-01
N0-vs-N1
2.759000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.898200E-01
Normal-vs-TP53-NonMutant
3.533000E-01
TP53-Mutant-vs-TP53-NonMutant
5.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
